中国民康医学
中國民康醫學
중국민강의학
MEDICAL JOURNAL OF CHINSEE PEOPLE HEALTH
2015年
2期
47-48
,共2页
米索前列醇片%宫颈成熟%引产
米索前列醇片%宮頸成熟%引產
미색전렬순편%궁경성숙%인산
Misoprostol tablets%Cervical ripening%Labor induction
目的::探索米索前列醇片在促待产妇宫颈成熟与引产的合适用法、用量。方法:选取待产妇168例,随机分成两组,A组待产妇舌下含服100μg米索前列醇片;B组待产妇阴道后穹隆置药50μg。收集两组待产妇用药后的宫颈成熟度、待产时间、产程以及新生儿安全指标等数据,进行统计学分析。结果:舌下含服和阴道给药在促待产妇宫颈成熟、有效率、待产时间、产程等作用上没有明显差别,但舌下含服组待产妇的剖宫产及新生儿窒息比率较低。结论:舌下含服100μg和阴道给药50μg米索前列醇片在有效性上效果相当,但舌下含服组的安全性更高。
目的::探索米索前列醇片在促待產婦宮頸成熟與引產的閤適用法、用量。方法:選取待產婦168例,隨機分成兩組,A組待產婦舌下含服100μg米索前列醇片;B組待產婦陰道後穹隆置藥50μg。收集兩組待產婦用藥後的宮頸成熟度、待產時間、產程以及新生兒安全指標等數據,進行統計學分析。結果:舌下含服和陰道給藥在促待產婦宮頸成熟、有效率、待產時間、產程等作用上沒有明顯差彆,但舌下含服組待產婦的剖宮產及新生兒窒息比率較低。結論:舌下含服100μg和陰道給藥50μg米索前列醇片在有效性上效果相噹,但舌下含服組的安全性更高。
목적::탐색미색전렬순편재촉대산부궁경성숙여인산적합괄용법、용량。방법:선취대산부168례,수궤분성량조,A조대산부설하함복100μg미색전렬순편;B조대산부음도후궁륭치약50μg。수집량조대산부용약후적궁경성숙도、대산시간、산정이급신생인안전지표등수거,진행통계학분석。결과:설하함복화음도급약재촉대산부궁경성숙、유효솔、대산시간、산정등작용상몰유명현차별,단설하함복조대산부적부궁산급신생인질식비솔교저。결론:설하함복100μg화음도급약50μg미색전렬순편재유효성상효과상당,단설하함복조적안전성경고。
Objective:To explore the appropriate use and dosage of misoprostol tablets in parturients with cervical ripening and labor induction. Methods:168 parturients were chosen and divided into two groups randomly. Group A parturients was given 100μg misoprostol tablets by sublingual administration, while 50μg misoprostol was placed in vaginal vault in group B parturients. The data of cervical maturity, expectant time, labor time and neonatal safety of the two groups parturients were collected for statistical analysis. Results:There were no differences in the cervical maturity, effective rate, expectant time and labor time between the two groups partu-rients, but the cesarean section and neonatal asphyxia rates were lower in the Group A parturients. Conclusions:The efficacies of both sublingual and vaginally groups are equivalent, but sublingual group is safer.